TOPIGEN PHARMACEUTICALS
Topigen Pharmaceuticals is a biotechnology company that is focused on the scientific research and development of therapeutic drugs. It develops treatments for respiratory disorders, including asthma and chronic obstructive pulmonary disease. Topigen Pharmaceuticals offers TPI ASM8, a drug that is developed for the management of moderate to severe asthma; and TPI 1100, a drug that is developed for the chronic obstructive pulmonary disease. Topigen Pharmaceuticals was acquired by Pharmaxis in January 2010. Topigen Pharmaceuticals was founded in 2000 and is based in Montreal, Quebec.
TOPIGEN PHARMACEUTICALS
Industry:
Biotechnology Developer Tools Product Research Therapeutics
Founded:
2000-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.topigen.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
28.6 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins IPv6 Contact Form 7
Similar Organizations
Jericho Sciences
Jericho Sciences is a focused on research and development of novel antiviral therapeutic and diagnostic products.
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2004-03-25 | Anagenis | Anagenis acquired by Topigen Pharmaceuticals | N/A |
Investors List
Caisse de Depot et Placement du Quebec
Caisse de Depot et Placement du Quebec investment in Series B - Topigen Pharmaceuticals
T2C2 Capital
T2C2 Capital investment in Series B - Topigen Pharmaceuticals
Business Development Bank of Canada
Business Development Bank of Canada investment in Series B - Topigen Pharmaceuticals
Innovatech Grand Montreal
Innovatech Grand Montreal investment in Series B - Topigen Pharmaceuticals
Desjardins Venture Capital
Desjardins Venture Capital investment in Series B - Topigen Pharmaceuticals
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series B - Topigen Pharmaceuticals
Desjardins Venture Capital
Desjardins Venture Capital investment in Venture Round - Topigen Pharmaceuticals
T2C2 Capital
T2C2 Capital investment in Venture Round - Topigen Pharmaceuticals
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Venture Round - Topigen Pharmaceuticals
Innovatech Grand Montreal
Innovatech Grand Montreal investment in Venture Round - Topigen Pharmaceuticals
Official Site Inspections
http://www.topigen.com
- Host name: 104.21.41.189
- IP address: 104.21.41.189
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
